New SPAC: Bellevue Life Sciences Files for $60M IPO to Acquire BioTech Business May 2, 2022 INTEL, New S-1 Filings by Marlena Haddad To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.
